Gilead Says Remdesivir Linked to a Reduction in Mortality Risk

(Bloomberg) -- Gilead Sciences Inc.’s remdesivir may help severely ill Covid-19 patients survive the deadly infection, according to a comparison of the company’s clinical-trial results to a real-wo...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.